The Friday Agency has been appointed to handle UK communications for Seed, a microbiome science company pioneering clinically and scientifically studied next-generation probiotics for human and planetary health. In collaboration with leading scientists and research partners from around the world, Seed’s platform enables the translation of breakthrough science across a portfolio spanning gastrointestinal and digestive health, women’s health, skin and oral care, paediatrics, mental health, metabolic function, and nutrition.

Their first product in the market, the award-winning DS-01 Daily Synbiotic, is a 24-strain broad-spectrum probiotic + prebiotic formulation developed for systemic benefits including digestive, skin, and heart health, micronutrient synthesis, and gut immune function.